Clinical impact of switching conventional enzyme immunoassay with nucleic acid amplification test for suspected Clostridium difficile-associated diarrhea

American Journal of Infection Control

Volumn 41, Issue 4, 2013, Pages 373-375

  Johnson, Steven W ^a,b   Kanatani, Meganne ^c   Humphries, Romney M ^d   Uslan, Daniel Z ^d  

^a CAMPBELL UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Clostridium difficile infection; DNA testing; Stool assay; Toxin testing

Indexed keywords

METRONIDAZOLE; RIFAXIMIN; VANCOMYCIN;

ADULT; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG COST; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID AMPLIFICATION;

ANTI-BACTERIAL AGENTS; CLINICAL LABORATORY TECHNIQUES; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS-SECTIONAL STUDIES; DIARRHEA; DRUG UTILIZATION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NUCLEIC ACID AMPLIFICATION TECHNIQUES;

EID: 84875535108     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2012.04.329     Document Type: Article

References (9)

1. S. Cohen, D. Gerding, S. Johnson, C. Kelly, V. Loo, and C. McDonald Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) Infect Control Hosp Epidemiol 31 2010 431 455
2. J. Ticehurst, D. Atird, L. Dam, A. Borek, T. Hargrove, and K. Carroll Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin J Clin Microbiol 44 2006 1145 1149
3. P. Stamper, R. Alcabasa, D. Aird, W. Babiker, J. Wehrlin, and I. Ikepama Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples J Clin Microbiol 47 2009 373 378
4. K. Eastwood, P. Else, A. Charlett, and M. Wilcox Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods J Clin Microbiol 47 2009 3211 3217
5. G. Terhes, E. Urban, J. Soki, E. Nacsa, and E. Nagy Comparison of a rapid molecular method, the BD Gene-Ohm Cdiff assay, to the most frequently used laboratory tests for detection of toxin-producing Clostridium difficile in diarrheal feces J Clin Microbiol 47 2009 3478 3481
6. F. Tenover, S. Novak-Weekley, C. Woods, L. Peterson, D. Thomas, and P. Schreckenberger Impact of strain type on detection of toxigenic Clostridium difficile: comparision of molecular diagnostic and enzyme immunoassay approaches J Clin Microbiol 48 2010 3719
7. S. Novak-Weekly, E. Marlowe, J. Miller, J. Cumpio, J. Nomura, and P. Vance Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms J Clin Microbiol 48 2010 889 893
8. J. Swindells, N. Brenwald, N. Reading, and B. Oppenheim Evaluation of diagnostic tests for Clostridium difficile disease J Clin Microbiol 48 2010 606 860
9. illumigene. Package insert. Cincinnati [OH]: Meridian Bioscience Inc; 2011.